Triple
T22796999
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | AveXis |
E564274
|
entity |
| Predicate | usesVector |
P37227
|
FINISHED |
| Object | AAV9 |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: AAV9 | Statement: [AveXis, usesVector, AAV9]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: AAV9 Context triple: [AveXis, usesVector, AAV9]
-
A.
AveXis
AveXis is a biotechnology company best known for developing the gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy.
-
B.
human adenovirus serotype 26 (Ad26)
Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
-
C.
E*Vax
E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
-
D.
HCV NS5A protein
HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
-
E.
CAAV
CAAV is the national regulatory body responsible for overseeing and managing civil aviation activities in Vietnam.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: AAV9 Target entity description: AAV9 is a serotype of adeno-associated virus widely used as a gene therapy vector, particularly valued for its ability to efficiently deliver genetic material to cells in the central nervous system and other tissues.
-
A.
AveXis
AveXis is a biotechnology company best known for developing the gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy.
-
B.
human adenovirus serotype 26 (Ad26)
Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
-
C.
E*Vax
E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
-
D.
HCV NS5A protein
HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
-
E.
CAAV
CAAV is the national regulatory body responsible for overseeing and managing civil aviation activities in Vietnam.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2458185f88190b0045227ee420411 |
completed | April 17, 2026, 2:36 p.m. |
| NER | Named-entity recognition | batch_69f17cd9b3c0819096050f43a829ec0d |
completed | April 29, 2026, 3:36 a.m. |
Created at: April 17, 2026, 3:30 p.m.